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SPIONs for cell labelling and tracking using MRI:
magnetite or maghemite?†
Michael Barrow, ‡a Arthur Taylor, ‡b Ana M. Fuentes-Caparrós,a Jack Sharkey,b
Luke M. Daniels, a Pranab Mandal,a B. Kevin Park,c Patricia Murray,b
Matthew J. Rosseinsky *a and Dave J. Adams *a,d
Although there is extensive literature covering the biomedical
applications of superparamagnetic iron oxide nanoparticles
(SPIONs), the phase of the iron oxide core used is not often taken
into account when cell labelling and tracking studies for regenera-
tive medicine are considered. Here, we use a co-precipitation
reaction to synthesise particles of both magnetite- (Fe3O4) and
maghemite- (γ-Fe2O3) based cores and consider whether the extra
synthesis step to make maghemite based particles is advantageous
for cell tracking.
Superparamagnetic iron oxide nanoparticles (SPIONs) are com-
monly used as cell tracking agents using magnetic resonance
imaging (MRI).1–3 SPIONs enhance contrast by altering the
transverse relaxation time of protons contained within sur-
rounding tissue. Many studies involving iron oxide nano-
particles for cell labelling applications fail to provide clear
characterisation of the core itself due to the well-known
diﬃculty in quantifying the ratio of magnetite and
maghemite.4–6 Both phases involve the occupation of octa-
hedral and tetrahedral sites within a close-packed array of
oxide anions.
Magnetite Fe3O4 is a spin polarised mixed valence metal
where 2/3 of the iron sites are Fe3+ and 1/3 Fe2+. Fe2+–Fe3+
intervalence charge transfer causes absorption throughout the
UV-vis and IR regions and hence magnetite appears black in
colour.7 Magnetite can slowly oxidise in aqueous conditions or
oxygen-containing environments at high temperatures to the
all-Fe3+ maghemite. However, oxidisation proceeds a lot slower
when stored as a powder at room temperature.8,9 Maghemite
(γ-Fe2O3), which is an oxidation product of magnetite (Fe3O4)
at temperatures below 200 °C, shows very little solution absor-
bance above 700 nm and appears brown-orange in colour.9
Both phases contain an inverse spinel face-centred cubic oxide
lattice with almost identical unit cell dimensions with lattice
parameters of a = 8.39 Å for Fe3O4
10 and either a = 8.34 Å or
8.35 Å for γ-Fe2O3 depending on method of synthesis,11,12
making it very diﬃcult to distinguish using powder X-ray diﬀr-
action (pXRD) alone.7,13 Maghemite is often termed Fe(II)
deficient or fully oxidised magnetite.13 Both magnetite and
maghemite are ferrimagnetic at sizes >20 nm.1 However, at
sizes below 20 nm, they both exhibit superparamagnetism
where they are only magnetised under the influence of an
external magnetic field, with zero coercivity, meaning a rever-
sal of field is not required to reduce magnetisation to zero.14
This property, as well as their relatively low toxicity, makes
these <20 nm SPIONs useful as contrast agent for MRI.1 For
regenerative medicine therapies, SPIONs have been extensively
used pre-clinically as cell tracking agents15,16 and have found
application in clinical research.1 The rationale behind these
studies is the monitoring of the localisation of SPION-labelled
cells (e.g., stem cells or macrophages) upon injection into the
host to better understand their biodistribution and therapeutic
mode of action. Importantly, this imaging technique is not
hindered by penetration depth or spatial resolution limitations
and can give detailed anatomical information.15,17,18 The
SPIONs consist of an iron oxide core surrounded by a polymer
shell that controls the core size and determines the colloidal
stability and cellular uptake of the SPIONs.
For most studies involving iron oxide nanoparticles as cell
labelling agents, characterisation of the iron oxide core i.e. the
amount of magnetite vs. maghemite is not often quoted and
the nanoparticles are often cited as being Fe3O4 or γ-Fe2O3
SPIONs without suﬃcient evidence to support either phase
being dominant. In general, so-called Fe3O4 cores are more
widely studied as contrast agents for cell tracking due to their
easier synthesis. Even though Fe3O4 has a slightly larger satur-
ation magnetisation than γ-Fe2O3, this is not likely to have a
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major eﬀect on the MRI contrast of exogenously labelled cells,
as previous studies showed that particles with diﬀerent satur-
ation magnetisation all have very similar relaxivities upon cell
internalisation.19 For increased contrast, it is necessary to
increase uptake, and for stem cells this is usually achieved by
use of a cationic polymer, which also renders SPIONs stable in
water and cell culture medium.19
To access pure phase γ-Fe2O3 nanoparticles, Fe3O4-contain-
ing materials are usually synthesised first followed by an oxi-
dation step. It has been claimed that the breakdown of Fe3O4
to γ-Fe2O3 could lead to toxicity issues in stem cells, where
Fe2+ ions released in the endosomes or lysosomes could cata-
lyse Fenton-type reactions leading to the formation of toxic
radicals.20 Some researchers prefer to oxidise particles before
cell labelling, which would avoid the problem of in vivo radical
formation, and have suggested that γ-Fe2O3 nanoparticles are
more stable to degradation in the acidic medium present in a
lysosomal environment.21 Therefore, there is a need to directly
relate the synthesis conditions of SPIONs with their core com-
position and overall eﬃciency as cell tracking agents for MRI.
Whilst there have been studies quantifying the amounts of
magnetite or maghemite in nanoparticles in general,4 as well
as magnetite oxidation,8,9 there are very few examples in the
literature linking this structural characterisation with their MR
performance in cells. As stated above, because of their very
similar unit cell dimensions it is diﬃcult to distinguish
between the two phases by pXRD alone due to peak broaden-
ing associated with very small core sizes. Some of the other
methods used to distinguish between the two phases are UV-
vis NIR spectroscopy,9 X-ray absorption near edge spec-
troscopy,22 Fourier transform infra-red spectroscopy (FTIR),4
Mössbauer spectroscopy6 and Raman spectroscopy.23 Raman
spectroscopy can sometimes be problematic if the laser power
is too high as it can actually oxidise magnetite.23 Park et al.
compared magnetite and maghemite nanoparticles for label-
ling alveolar macrophages and concluded that maghemite is
the less toxic of the two.24 However, definitive characterising
data to establish the identities of the iron oxide phases in the
cores of these SPIONs were not presented, colloidal stability
was not quoted and the hydrodynamic diameters and zeta
potentials were quite diﬀerent in the two cases, which could
aﬀect both uptake and toxicity.
We propose that to accurately compare SPIONs based on
diﬀerent dominant iron oxide core phases for cell labelling
and tracking using MRI, we must attempt to control other
physicochemical properties which could aﬀect their toxicologi-
cal profile. Here, we have synthesised SPIONs with diﬀerent
dominant phases of iron oxide in the core and report their
hydrodynamic diameter, zeta potential, polymer coating and
content and core size.
We used a synthesis method similar to one we have pre-
viously employed, where we showed that varying the ratio of
fluorescein isothiocyanate (FITC)-diethylaminoethyl (DEAE)
dextran to iron salts used in the co-precipitation reaction can
control the core size of synthesised SPIONs and their uptake
in mouse mesenchymal cells and macrophages.19,25,26 To syn-
thesise SPIONs with a magnetite core, we used a ∼1 : 1 DEAE-
dextran (non FITC-containing) polymer to iron salt ratio and
carried the reaction out under nitrogen (see ESI† for full
Materials and methods). The resulting SPIONs were oxidised
by exposing the magnetite samples to air, attaching a reflux
condenser and heating at 110 °C in air for a period of 5 hours.
During the synthesis, aliquots taken at various time points
(Fig. 1) show the characteristic change in colour from black
(magnetite) to orange (maghemite) and the corresponding loss
in absorbance above 650 nm. Aliquots were taken at time
t = 0 hours, which is directly after the synthesis under
nitrogen, then at t = 1 hours, t = 3 hours, and t = 5 hours after
the samples were exposed to air and heated to reflux.
These samples were then stored under nitrogen until
further measurements were carried out. The loss in absor-
bance and colour change with time were similar to what was
observed by Tang et al. over the same time period, where they
claimed full conversion to maghemite.9 Samples t = 0 hours
and t = 5 hours were selected to be compared for cell labelling
as t = 0 hours had the highest NIR absorption, indicating the
highest content of magnetite present. However, it is not poss-
ible to calculate the absolute amount of magnetite from this
measurement alone. Both materials have characteristic iron
oxide reflections by pXRD with lattice parameters of a = 8.37 Å
for t = 0 hours and a = 8.35 Å for t = 5 hours indicating the
unit cell has got smaller. The particle core sizes are very
similar 8.8 nm for t = 0 hours and 9.1 nm for t = 5 hours, as
calculated using the Scherer equation (Table 1 & Fig. S1†). The
hydrodynamic diameters were 86.7 nm for t = 0 hours and
64.4 nm for t = 5 hours in 0.01 M NaCl (Table 1, Fig. S2 &
Table S2†) and the overall polymer coverage, which was calcu-
lated using thermogravimetric analysis (TGA) to be 82.1% for
the sample t = 0 hours and 80.2% for the sample t = 5 hours
(Table 1 and Fig. S3†). The slightly lower polymer content
for the 5 hours sample could be a result of the extra oxidation
step causing some polymer to detach from the surface,
which also resulted in a decrease in the hydrodynamic diameter
from 86.7 nm to 64.4 nm. Importantly, the surface charge
(apparent zeta potential) is also maintained with a minimal
drop from 19.9 mV for t = 0 to 19.0 mV for the t = 5 hours
sample. Transmission electron microscopy (TEM) showed that
Fig. 1 (a) Picture showing 5 mL aliquots taken from the reaction
mixture at (from left to right) t = 0, 1, 3 and 5 hours post-exposure to
air. (b) The corresponding loss of absorbance above ∼650 nm for the ali-
quots removed from the reaction mixture.
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particles had very similar size and morphology (Fig. S4†).
Magnetisation curves (Fig. S5†) showed a decrease in saturation
magnetisation from 115 emu g−1 [Fe] to 95 emu g−1 [Fe], a
further evidence of oxidation as magnetite has a larger satur-
ation magnetisation than maghemite.7 We have quoted values
in emu g−1 [Fe], as this is a more representative quantity when
the precise phase present is unknown.19
To investigate the phase of the iron oxide core in more
detail, we used the same co-precipitation reaction as before,
with the only diﬀerence being that no polymer is used in the
synthesis. This protocol also yields particles with core sizes of
around 10 nm. X-ray absorption near-edge spectroscopy
(XANES) was used to determine the average oxidation state of
iron in samples prepared at t = 0 hours and at t = 5 hours with
respect to commercially available standard materials with
known stoichiometry (Fig. 2a). When the edge energy was
plotted with respect to the oxidation states (Fig. 2b) of the
standard materials, the sample prepared at t = 0 hours had an
average iron oxidation state of +2.8, which confirms that the
majority phase is magnetite (60%) with 40% being maghemite.
For the sample prepared at t = 5 hours, the edge energy
matches that of γ-Fe2O3, which gives an average iron oxidation
state of +3 confirming that the extra oxidation step converts all
the iron oxide to pure maghemite. These edge values are
similar to iron oxide values published elsewhere.22
When SPIONs are taken up by stem cells, they have been
shown in numerous studies to be preferentially localised
within endosomes, which have local pH in the 4.5–5.5 range.27
However, assessing the stability of iron oxide nanoparticles
within cells can be diﬃcult. Some researchers have suggested
using acidic buﬀers containing citrate as a lysosomal mimic
for understanding particle degradation.28 Whilst this tech-
nique is employed for comparative purposes and can give an
idea if one sample is ‘more stable’ than another, it must be
noted that the method does not reproduce the exact conditions
found in lysosomes and thus, it can be diﬃcult to correlate
such degradation data with the particle’s stability in cells or
in vivo. In general, the citrate assay is likely to overestimate the
kinetics of particle dissolution, where published data suggest
nearly full dissolution after just a few days.27 On the other
hand, when actual cells are imaged post SPION labelling, sig-
nificant contrast by MR is often observed for weeks.27 In
Fig. 3a, we show dissolution of the SPIONs prepared at t =
0 hours and at t = 5 hours in citrate buﬀer at pH 4.5. The
SPIONs prepared at t = 0 hours dissolve at a much faster rate
than those prepared at t = 5 hours. After 48 hours exposure to
the citrate buﬀer solution, for example, the SPIONs prepared
at t = 0 hours are more than 90% dissolved whereas the
samples prepared at t = 5 hours are only 30–40% dissolved. In
Fig. 3b, we have compared solution relaxivity, which is often
quoted as a means of understanding SPION eﬃciency as MR
contrast agent, before and after 48 h exposure to citrate buﬀer.
As we and others have previously shown that T*2 sequences are
more sensitive for tracking labelled cells, we compare T*2 relax-
ivity here (methods described in ESI†).19 For the stock solu-
tions, the SPIONs prepared at t = 0 hours have a relaxivity of
452 mM−1 s1 and the SPIONs prepared at t = 5 hours have a
value of 298 mM−1 s−1. The lower relaxivity for t = 5 h (maghe-
mite) is expected given its lower saturation magnetisation.
After 2 days in citrate buﬀer at pH 4.5, the T*2 eﬀect of SPIONs
prepared at t = 0 hours is completely lost, with its relaxivity
decreased to 22 mM−1 s−1. The relaxivity for the SPIONs pre-
pared at t = 5 hours, in contrast, only drops slightly to
270 mM−1 s−1, showing agreement with the dissolution data in
Table 1 Properties of SPIONs at t = 0 hours and t = 5 hours post-exposure to air
Sample Core size pXRD (nm)
Hydrodynamic Z-avg in
0.01 M NaCl (nm)
Zeta potential in
0.01 M NaCl (mV)
Polymer content
by TGA (%)
t = 0 hours 8.8 86.7 19.9 82.1
t = 5 hours 9.1 64.4 19.0 80.2
Fig. 2 (a) The experimental Fe K-edge XANES spectra of samples pre-
pared at t = 0 hours and at t = 5 hours and standard materials (smaller
energy range shown in ESI Fig. S6†). (b) Edge energies plotted with
respect to oxidation states of standards.
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Fig. 3a. MR images reflecting the change in contrast gene-
ration at 0.25 mM before and after exposure to pH 4.5 are
shown as insets in Fig. 3b. Although relaxivity values are used
here for comparative purposes of stability, the values may not
reflect the actual dissolution in cells, for the reasons discussed
above.
To assess the suitability of these materials to label cells, we
exposed a mouse mesenchymal/stromal stem cell line (ATCC
CRL-12424) to a concentration of 10 μg mL−1 [Fe] of each
SPION for a period of 24 h. This resulted in equivalent intra-
cellular levels of ∼9.1 pg [Fe] per cell (Fig. 4a) for both
samples, highlighting how their equivalent shell properties
(size and zeta potential) lead to similar uptakes.
Importantly, this is an intracellular iron concentration that
has previously been shown to yield strong MRI contrast
in vivo.27 Viability measurements obtained by quantification of
ATP (Fig. 4b, see ESI† for methods) revealed that neither of the
two samples, irrespective of a core consisting predominantely
of magnetite or maghemite, were toxic, with ATP levels equi-
valent to those found for controls (unlabelled cells).
We then sought to investigate the long-term stability of
each SPION in lysosomes and, in particular, whether they
agree with the data obtained with the citrate method shown as
shown in Fig. 3b. For that purpose, we arrested the MSCs
immediately after SPION labelling by exposure to Mitomycin-C
(20 µg mL−1, 4 hours), and kept them in an humidified incu-
bator for up to 14 days with regular medium changes.
Mitomycin-C is a DNA crosslinker that stops cell prolifer-
ation and thus prevents dilution of the SPIONs between
daughter cells. We then compared how these MSCs generate
MR contrast at three time points: directly after labelling, 2 days
after labelling (i.e. equivalent to the conditions in Fig. 3b) and
2 weeks after labelling (Fig. 5).
Cells were harvested at each time point, fixed with formal-
dehyde, and then suspended in agarose at a concentration of
1.5 × 103 cells per µL, which is equivalent to ∼0.25 mM of Fe
when a uptake of 9.1 pg per cell is considered. Each of these
samples was then imaged via MR with a T*2 sequence
(described in ESI†), where any significant intracellular degra-
dation of SPIONs should lead to a loss of negative contrast.
Interestingly, at all 3 time points, the level of negative contrast
is similar, irrespective of the SPION phase (t = 0 hours or t =
5 hours). Samples imaged 2 weeks post-labelling displayed a
noticiable increase in signal loss, which is likely due to SPION
transfer from dying cell debris to the remaining, viable, cells.
It should be noted that a small fraction of cells undergo apop-
tosis during a two week culture period, and the uptake of
SPION debris to viable cells has been previously shown in the
literature.29 Strikingly, there is no indication of degradation
Fig. 3 (a) Dissolution of SPIONs in citrate buﬀer system at pH 4.5 at
37 °C for 14 days (b) T*2 solution relaxivity of SPIONs before and after
exposure to citrate buﬀer for 2 days. MR images correspond to a con-
centration of 0.25 mM as imaged with a MGE sequence at TE = 15.5 ms.
Fig. 5 T*2 weighted MR images of MSCs labelled with SPIONs at
diﬀerent time points. Controls consist of an equivalent number of
unlabelled cells or agarose only.
Fig. 4 (a) Uptake (calculated probability p = 0.8 between the diﬀerent
particles) and (b) viability (p = 0.56 between the diﬀerent materials) of
MSCs labelled with 10 µg mL−1 SPIONs for 24 hours. Triton-X 100 (0.1%)
was used as a negative control to induce cell death.
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for either of the SPIONs, regardless of whether the iron oxide
core consists predominantely of magnetite or maghemite. This
is in strong contrast to Fig. 3b, where the SPIONs that consist
predominantely of magnetite (t = 0 hours) were nearly fully
degraded and unable to generate contrast when placed in
citrate buﬀer at pH 4.5 for 2 days. This highlights how the
degradation kinetics can be extremely misleading under con-
ditions that do not accurately reflect the environments found
in cells. In fact, even the hypointense signal generated by cells
14 days post–labelling is similar for both sets of SPIONs,
suggesting that irrespective of the predominant phase of the
core, the SPIONs internalised in cells remain very stable for
long periods of time. For example, we have previously shown
that SPIONs used to label macrophages can generate MR
signal in vivo for up to 1 month.26 The same observations were
made when imaging the same samples using T2 weighted
sequences (Fig. S7†).
Conclusions
We have shown using UV-Vis-NIR, XANES and pXRD that it is
possible to use co-precipitation to synthesise SPIONs that
contain predominantly magnetite or pure phase maghemite
and we have compared them for cell tracking purposes. Whilst
a citrate buﬀer lysosomal mimic indicates that maghemite par-
ticles could be significantly more stable in the long term, in
fact, when particles are internalised in MSCs their stability is
largely the same as the predominantly magnetite containing
SPIONs and the MR signal is retained for up to at least two
weeks. Thus, it is not possible to establish any major diﬀer-
ences between the MR performance of either phase in the
time frame of most pre-clinical studies, particularly when
imaging lasts less than 14 days. This could mean that when
the production of these materials is considered, the extra oxi-
dation step and synthesis time may not be required for cell
tracking purposes. This study further indicates the need to
characterise SPIONs and other nanomaterials before and after
exposure to physiological conditions to better understand
their performance in vivo.
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